An observational study in Breast Cancer and Thyroid Diseases, sponsored by Uşak University. Completed. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-05-28.
Sponsored by Uşak University · Observational
Breast cancer and thyroid disorders are important health challenges commonly encountered in women. The relationship between both conditions still remains unknown. In this study, the frequency of thyroid diseases was investigated in breast cancer patients
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 160 is below the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Uşak University is the lead sponsor of 78 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
women, aged between 18-65 years who were diagnosed with breast cancer, but not underwent surgery, radiotherapy or chemothreapy were included into the study as patients groups. Age matched healthy controls were enrolled as controls.
Exclusion Criteria:
Patients with breast cancer
Device: thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
Healthy patients without breast cancer
Device: thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
to investigate the frequency of thyroid diseases in breast cancer patients.
Time frame: 1 year
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uşak University